ID   TGBC51TKB
AC   CVCL_H694
SY   TGBC-51TKB; TGBC-51
DR   CLO; CLO_0050116
DR   RCB; RCB1281
DR   Wikidata; Q54972245
RX   CelloPub=CLPUB00275;
RX   PubMed=9824643;
RX   PubMed=15645130;
CC   Population: Japanese.
CC   Doubling time: 96 hours (PubMed=9824643); 94 +- 0.1 hours (PubMed=15645130).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): RCB
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C27418; Ampulla of Vater adenosquamous carcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H693 ! TGBC50TKB
OI   CVCL_H695 ! TGBC52TKB
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 16
//
RX   CelloPub=CLPUB00275;
RA   Zach S., Birgin E., Ruckert F.;
RT   "Primary cholangiocellular carcinoma cell lines.";
RL   J. Stem Cell Res. Transplant. 2:1013-1013(2015).
//
RX   PubMed=9824643; DOI=10.3892/ijo.13.6.1269;
RA   Koike N., Todoroki T., Kawamoto T., Yoshida S., Kashiwagi H.,
RA   Fukao K., Ohno T., Watanabe T.;
RT   "The invasion potentials of human biliary tract carcinoma cell lines:
RT   correlation between invasiveness and morphologic characteristics.";
RL   Int. J. Oncol. 13:1269-1274(1998).
//
RX   PubMed=15645130; DOI=10.3892/ijo.26.2.449;
RA   Ghosh M., Koike N., Tsunoda S.-i., Hirano T., Kaul S., Kashiwagi H.,
RA   Kawamoto T., Ohkohchi N., Saijo K., Ohno T., Miwa M., Todoroki T.;
RT   "Characterization and genetic analysis in the newly established human
RT   bile duct cancer cell lines.";
RL   Int. J. Oncol. 26:449-456(2005).
//